NewAmsterdam Pharma Co N.V. (NAMS) · Fund holders
Which of the 64 well-known fund managers followed here own NewAmsterdam Pharma, from the 13F each files after a quarter's end, and what each did in its latest quarter.
Held by
4
of 64 funds
Their stake
$259.03M
together
Bought
2
1 new, 1 added
Sold
0
0 sold out
The funds
| Fund | Share of its portfolio | Shares | Value | Latest quarter |
|---|---|---|---|---|
| Viking Global Investors2026-06-30 | 0.41% | 4,203,567 | $142.46M | Unchanged |
| Maverick Capital2026-06-30 | 1.00% | 3,267,802 | $110.75M | Added 49% |
| Point72 Asset Management (Steve Cohen)2026-06-30 | 0.01% | 168,901 | $5.72M | New |
| Duquesne Family Office (Stanley Druckenmiller)2026-06-30 | 2.39% | 3,070,146 | $104,047 | Unchanged |
A 13F shows a quarter's end and is filed up to 45 days later, so this is not what the funds hold today. All funds ›